Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
05/18/2007 | WO2007034282A3 Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists |
05/18/2007 | WO2007034278A3 Fused imidazole derivatives as c3a receptor antagonists |
05/18/2007 | WO2007029037A3 Class iia histone deacetylase (hdac) substrate |
05/18/2007 | WO2007029035A3 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
05/18/2007 | WO2007027719A3 Lisofylline analogues and their pharmeacuetical uses |
05/18/2007 | WO2007025540A3 Substituted imidazo[1,2b]pyridazines as kinase inhibitors, the production thereof, and use of the same as medicaments |
05/18/2007 | WO2007023111A3 P38 map kinase inhibitors and methods for using the same |
05/18/2007 | WO2007012953A3 Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis |
05/18/2007 | WO2007002254A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
05/18/2007 | CA2669736A1 Heterocyclic compounds as tyrosine kinase modulators |
05/18/2007 | CA2628937A1 Tetracyclic indole derivatives as antiviral agents |
05/18/2007 | CA2627349A1 Azaindole compounds and use thereof as phospholipase-a2 inhibitors |
05/18/2007 | CA2627089A1 1 h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
05/18/2007 | CA2627043A1 Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors |
05/18/2007 | CA2608726A1 Inhibitors of vegf receptor and hgf receptor signaling |
05/17/2007 | US20070112172 Forming polymer; electronics |
05/17/2007 | US20070112043 Acylated and non-acylated imidazo[2,1-b]-1,3,4,-thiadiazole-2-sulfonamides, and uses thereof |
05/17/2007 | US20070112015 Substituted dihydropyridines and methods of use |
05/17/2007 | US20070112008 Saframycins, analogues and uses thereof |
05/17/2007 | US20070112006 such as (7-methyl-5-trifluoromethyl-1,2,4-triazolo[1,5-a]pyrimidin-2-yl)-[3-(2-(N-methylaminocarbonyl)pyridin-4yloxy)phenyl]amine, used as tyrosine kinase inhibitors for the treatment of tumors |
05/17/2007 | US20070112005 Fused bicyclic mTOR inhibitors |
05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
05/17/2007 | US20070111997 Triazolopyrimidines and related analogs as HSP90-inhibitors |
05/17/2007 | US20070111996 Pyrazolopyrimidines and related analogs as HSP90-inhibitors |
05/17/2007 | US20070111989 Novel diazabicyclononene derivatives and use |
05/17/2007 | US20070111927 Peptoid compounds |
05/17/2007 | US20070111889 6-(Aminocarbonyl-phenyl)triazolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same |
05/17/2007 | US20070111123 Titanyl phthalocyanin crystal, method for preparing the same and electrophotographic photoconductor |
05/17/2007 | US20070108441 Switching device |
05/17/2007 | US20070108438 Multypodal tethers for high-density attachment of redox-active moieties to substrates |
05/16/2007 | EP1785424A2 Fused 1,2,4-triazoles and pharmaceutical uses thereof |
05/16/2007 | EP1785415A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
05/16/2007 | EP1784410A2 Antibacterial agents |
05/16/2007 | EP1784408A1 Triazolobenzodiazepines and their use as vasopressin antagonists |
05/16/2007 | EP1784390A2 Substituted benzofused heterocycles |
05/16/2007 | EP1784188A2 Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
05/16/2007 | EP1784186A2 Methods for treating or preventing erectile dysfunction or urinary incontinence |
05/16/2007 | EP1784175A2 Inhibitors of akt activity |
05/16/2007 | EP1699799B1 Control of parasites in animals by the use of imidazo [1,2-b]pyridazine derivatives |
05/16/2007 | EP1534714B1 Liquid crystal display and colour filter with improved transparency for green light |
05/16/2007 | EP1534712B1 Pyrazolo[1,5-a]pyrimidine compounds as cyclin dependent kinase inhibitors |
05/16/2007 | EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
05/16/2007 | EP1063237B1 Method for preparing metal complex of porphyrin |
05/16/2007 | CN1964975A Hiv整合酶抑制剂 Hiv integrase inhibitors |
05/16/2007 | CN1964974A 1, 2, 4-triazolo[1,5a]pyrimidines and use thereof for controlling plant-pathogenic fungi |
05/16/2007 | CN1964973A Pyrrazolo-pyrimidine derivatives |
05/16/2007 | CN1964970A Iap的抑制剂 Iap inhibitors |
05/16/2007 | CN1964954A 吡唑并嘧啶类 Pyrazolo pyrimidine |
05/16/2007 | CN1964629A Triazolopyrimidine compounds and use thereof for controlling harmful fungi |
05/16/2007 | CN1962663A Tetrabenzothiazolyl porphyrin metal complex |
05/16/2007 | CN1962662A Triazolo-pyrimido-thioacetamide compounds, preparation method and uses |
05/16/2007 | CN1315850C Axial substituted phthalocyanine compound, its preparation and application in optical kinetic treatment |
05/16/2007 | CN1315835C Polycyclic guanine phosphodiesterase v inhibitors |
05/16/2007 | CN1315834C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
05/16/2007 | CN1315833C Azaindole kinase inhibitors |
05/16/2007 | CN1315832C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives |
05/16/2007 | CN1315831C Direct preparation of pyrrolo [3,4-c] pyrroles compounds |
05/16/2007 | CN1315830C Substituted purine new compound with anti-HIV activity, preparing method and use |
05/16/2007 | CN1315809C Quinoline derivatives and their use as 5-HT6 ligands |
05/15/2007 | US7217728 For therapy of reperfusion injury |
05/15/2007 | US7217717 Antiproliferation agents; anticancer agents; tyrosine kinase inhibitor |
05/15/2007 | US7217716 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate NR2B antagonists |
05/15/2007 | US7217715 Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
05/15/2007 | US7217711 Piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutical compositions |
05/15/2007 | US7217710 Pyrazolo-pyrimidine compound; anticancer agents |
05/15/2007 | CA2470560C A process for producing phenserine and its analog |
05/15/2007 | CA2374767C Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof |
05/15/2007 | CA2149419C Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds |
05/10/2007 | WO2007053352A2 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands |
05/10/2007 | WO2007053192A2 Multipodal tethers for high-density attachment of redox-active moieties to substrates |
05/10/2007 | WO2007052843A1 Heterocyclic amide compound and use thereof |
05/10/2007 | WO2007051947A1 Novel electropolymerisable monomers which are soluble in an aqueous solution and comprise a metalloporphyrine |
05/10/2007 | WO2007051496A1 Process for the preparation of n-triazinylammonium salts |
05/10/2007 | WO2007029029A3 Tetracyclic indole derivatives as antiviral agents |
05/10/2007 | WO2007023281A3 Biologically active compounds |
05/10/2007 | WO2007022102A3 Pentacyclic kinase inhibitors |
05/10/2007 | WO2007018808A3 Methods and intermediates for the synthesis of porphyrins |
05/10/2007 | WO2007002701A3 Anti-inflammatory aryl nitrile compounds |
05/10/2007 | WO2007002667A3 Azaindazole compounds and methods of use |
05/10/2007 | WO2006131835A3 Heterocyclic triazines as hypoxic selective protein kinase inhibitors |
05/10/2007 | WO2006120573A3 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors |
05/10/2007 | WO2006113875A3 2 - pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain |
05/10/2007 | WO2005103056A3 Preparation of metal mesoporphyrin halide compounds |
05/10/2007 | US20070106076 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino [1,2-a] indoles |
05/10/2007 | US20070105897 Novel quinuclidine derivatives and medicinal compositions containing the same |
05/10/2007 | US20070105877 Pyrazolopyrimidines |
05/10/2007 | US20070105876 6-Cyclylmethyl- and 6-alkylmethyl-substituted pyrazolepyrimidines |
05/10/2007 | US20070105865 Substituted bicyclic quinazolin-4-ylamine derivatives |
05/10/2007 | US20070105863 e.g. 1-(8-(3-hydroxyphenyl)-7,8-dimethyl-hexahydro-1H-pyrido[1,2- alpha ]pyrazin-2(6H)-yl)-2-phenylethanone; analgesics; gastrointestinal dysfunction, post-surgical recovery; side effect reduction |
05/10/2007 | US20070105856 6-benzyl-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-2,6-dihydropyrazolo[3,4-c]pyridin-7-one; eating and psychological disorders; obesity, alcoholism |
05/10/2007 | US20070105032 Titanyl phthalocyanine crystal and manufacturing method thereof and electrophotographic photoreceptor and electrophotographic imaging apparatus using the photoreceptor |
05/10/2007 | CA2626350A1 Compounds and compositions as protein kinase inhibitors |
05/09/2007 | EP1782800A2 JAK/STAT pathway inhibitors and the uses thereof |
05/09/2007 | EP1781664A1 Inhibitors of vegf receptor and hgf receptor signaling |
05/09/2007 | EP1781663A2 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
05/09/2007 | EP1781662A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
05/09/2007 | EP1781661A2 Vasopressin v1a antagonists |
05/09/2007 | EP1781660A1 Imidazopyrazine as tyrosine kinase inhibitors |
05/09/2007 | EP1781659A2 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
05/09/2007 | EP1781656A2 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |